CHOLESTERYL ESTER TRANSFER IN TYPE-2 DIABETIC-PATIENTS

被引：0
|
作者：
MURAKAMI, T
MIZUSHIMA, Y
GIANFRANCESCHI, G
SIRTORI, CR
FRANCESCHINI, G
机构：
[1] UNIV MILAN,I-20122 MILAN,ITALY
[2] ST MARIANNA UNIV,SCH MED,INST MED SCI,KAWASAKI,KANAGAWA 213,JAPAN
来源：
DIABETOLOGIA | 1995年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A249 / A249
页数：1
相关论文
共 50 条
  • [21] MICROALBUMINURIA IN A POPULATION OF 653 TYPE-1 AND TYPE-2 DIABETIC-PATIENTS
    DESCAMPS, O
    BUYSSCHAERT, M
    KETELSLEGERS, JM
    HERMANS, M
    LAMBERT, AE
    DIABETES & METABOLISM, 1991, 17 (05): : 469 - 475
  • [22] PROXIMAL FEMUR DENSITY IN TYPE-1 AND TYPE-2 DIABETIC-PATIENTS
    BUYSSCHAERT, M
    CAUWE, F
    JAMART, J
    BRICHANT, C
    DECOSTER, P
    MAGNAN, A
    DONCKIER, J
    DIABETES & METABOLISM, 1992, 18 (01): : 32 - 37
  • [23] The effect of apolipoprotein E polymorphism on plasma cholesteryl ester transfer protein activity in type 2 diabetic patients
    Chaaba, R.
    Attia, N.
    Hammami, S.
    Smaoui, M.
    Ben Hamda, K.
    Mahjoub, S.
    Hammami, M.
    MOLECULAR BIOLOGY, 2008, 42 (06) : 829 - 833
  • [24] VISUAL IMPAIRMENT IN TYPE-2 DIABETIC-PATIENTS - A MULTICENTER STUDY IN FRANCE
    DELCOURT, C
    VILLATTECATHELINEAU, B
    VAUZELLEKERVROEDAN, F
    CATHELINEAU, G
    PAPOZ, L
    BENSOUSSAN, D
    FALLAS, PR
    CUNY, P
    MALINSKI, M
    HUMBERT, P
    CHOPINET, P
    PERDOUX, L
    MOYENIN, P
    GRENIER, JL
    GROSS, P
    MALBREL, P
    HOULBERT, D
    LANGLOIS, JL
    JELLAL, M
    LAURENT, C
    CHAGNON, A
    POUGETABADIE, HF
    CARRE, H
    VENOT, J
    CAVIGNEAUXDECOURTEL, I
    VIOLANTE, A
    MASSABIE, P
    LEID, J
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 1995, 73 (04): : 293 - 298
  • [25] The effect of apolipoprotein E polymorphism on plasma cholesteryl ester transfer protein activity in type 2 diabetic patients
    R. Chaaba
    N. Attia
    S. Hammami
    M. Smaoui
    K. Ben Hamda
    S. Mahjoub
    M. Hammami
    Molecular Biology, 2008, 42 : 829 - 833
  • [26] PLASMA-LIPID LEVELS AT DIAGNOSIS IN TYPE-2 DIABETIC-PATIENTS
    SOSENKO, JM
    KATO, M
    SOTO, R
    GOLDBERG, RB
    DIABETIC MEDICINE, 1993, 10 (09) : 814 - 819
  • [27] ERYTHROCYTE SIALIC-ACID AND FILTERABILITY IN TYPE-2 DIABETIC-PATIENTS
    LIPOVAC, V
    GAVELLA, M
    CRNEK, S
    RUBINJONI, Z
    CLINICAL HEMORHEOLOGY, 1990, 10 (05): : 477 - 483
  • [28] DECREASED COGNITIVE FUNCTION IN TYPE-2 DIABETIC-PATIENTS WITH AUTONOMIC NEUROPATHY
    GROSS, JL
    ZASLAVSKY, LMA
    HUANG, CH
    MACHADO, R
    CHAVES, MLF
    DIABETOLOGIA, 1993, 36 : A185 - A185
  • [29] CO-OCCURRENCE OF HYPERCALCIURIA AND HYPOURICEMIA IN TYPE-2 DIABETIC-PATIENTS
    ISHIHARA, M
    SHINODA, T
    YAMADA, T
    DIABETIC MEDICINE, 1989, 6 (05) : 406 - 411
  • [30] ERYTHROCYTE COMPOUNDS AND RHEOLOGY IN TYPE-2 DIABETIC-PATIENTS - EFFECT OF PRAVASTATIN
    MIOSSEC, P
    GARNIER, M
    PARIES, J
    ZKIRI, F
    AMELINEAU, E
    ATTALAH, M
    ATTALI, JR
    VALENSI, P
    DIABETOLOGIA, 1995, 38 : A258 - A258
12345